Category :

ATHENS – October 1nd, 2014 – FINVENT S.A., a high-performance niche software solutions provider for the Investment Management Industry, participated for the second consequent year, in Greece Race for the Cure®, held in Athens, on Sunday 28 September 2014.

Greece Race for the Cure®, which is approved by the International Organization “Susan G. Komen for the Cure®”, is a charity event aimed at sponsoring the Greek Society of Women with Breast Cancer. Finvent Team was there to honor all the women who have fought or are still fighting their battle against cancer.
The Race took place around the center of Athens and the number of participants exceeded everybody’s expectations, as more 18.000 people started off in the run this year!

“Finvent is a socially responsible company actively supporting “good causes” in the past several years.  This action was organized directly by the Finvent employees, who demonstrated in a practical manner their emotional-alignment to cancer patients.” said Mr. Makis Ioannou, Finvent CEO. “It is really important for everyone to help so that the cure to cancer can be found.”


About Finvent
Finvent S.A., founded on 2001 as the exclusive distributor of Advent Software Solutions and a certified Advent Software outsourced partner, provides best-of-breed applications and professional services to all types of asset management firms, bank private & wealth management divisions, mutual funds and hedge funds, fund administrators and family offices, organizations based in South Eastern Europe, Italy, Malta, Iberia, Middle-East and Africa.
With operations in Cyprus, Greece and Spain and clients in over 13 countries in the region, Finvent is a leading provider of trusted software applications and related full range of pre-implementation and post-implementation services, which are designed to provide quick return-on-investment to money managers.
Finvent is a silver ISV partner to Microsoft and is an ISO 9001-2000 certified company.

Contact Details:
Finvent Marketing Department
+30 210 33 17 374